Civitas Solutions (NYSE: CIVI) is one of 127 publicly-traded companies in the “MEDICAL CARE” industry, but how does it weigh in compared to its rivals? We will compare Civitas Solutions to related businesses based on the strength of its earnings, analyst recommendations, institutional ownership, risk, profitability, valuation and dividends.
Earnings & Valuation
This table compares Civitas Solutions and its rivals revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Civitas Solutions||$1.47 billion||$6.33 million||48.23|
|Civitas Solutions Competitors||$7.60 billion||$240.26 million||-13,317.87|
This table compares Civitas Solutions and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Civitas Solutions Competitors||-68.28%||-652.99%||-22.79%|
This is a breakdown of recent ratings and target prices for Civitas Solutions and its rivals, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Civitas Solutions Competitors||719||3453||5307||128||2.50|
Civitas Solutions currently has a consensus price target of $20.00, indicating a potential upside of 33.78%. As a group, “MEDICAL CARE” companies have a potential upside of 9.98%. Given Civitas Solutions’ stronger consensus rating and higher probable upside, analysts plainly believe Civitas Solutions is more favorable than its rivals.
Institutional & Insider Ownership
94.6% of Civitas Solutions shares are owned by institutional investors. Comparatively, 59.7% of shares of all “MEDICAL CARE” companies are owned by institutional investors. 5.3% of Civitas Solutions shares are owned by insiders. Comparatively, 16.6% of shares of all “MEDICAL CARE” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Risk and Volatility
Civitas Solutions has a beta of 0.76, indicating that its share price is 24% less volatile than the S&P 500. Comparatively, Civitas Solutions’ rivals have a beta of 1.25, indicating that their average share price is 25% more volatile than the S&P 500.
Civitas Solutions beats its rivals on 8 of the 13 factors compared.
About Civitas Solutions
Civitas Solutions, Inc. is a provider of home- and community-based health and human services to individuals with intellectual, developmental, physical or behavioral disabilities and other special needs. The Company operates through two segments: Human Services and Post-Acute Specialty Rehabilitation Services (SRS). The Human Services segment provides home- and community-based human services to individuals with intellectual and/or developmental disabilities (I/DD), youth with emotional, behavioral and/or medically complex challenges or at-risk youth (ARY), and elders. The SRS segment delivers healthcare and community-based health and human services to individuals having suffered acquired brain injury, spinal injuries, and other catastrophic injuries and illnesses. Within its SRS segment, its NeuroRestorative business unit is focused on rehabilitation and transitional living services, and its CareMeridian business unit is focused on the medically-intensive post-acute care services.
Receive News & Ratings for Civitas Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Civitas Solutions and related companies with MarketBeat.com's FREE daily email newsletter.